drugset
drugset / Trial / NCT00029185

Study of Dehydrex in Patients With Corneal Erosion

NCT00029185 ↗

Completed 300 enrolled Holles Laboratories, Inc.
RandomizedSingle-groupDouble-blindTreatment

Summary

This is a compassionate-use treatment study to provide Dehydrex to patients with corneal erosion syndrome who have previously used Dehydrex.

Timeline

Start
2001-09
Primary completion
—
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydrex Unknown — —

Indications

corneal disorder